The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma
Marmara Medical Journal · 31.01.2023 · 36 (1) · 65-71
DOI: 10.5472/marumj.1244684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marmara Medical Journal, online erschienen am 31.01.2023. Verfasst von Ayse UYSAL und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Mobilisation
Abstract (Originalsprache)
Objective: The aim of this study is to investigate the effect of the preemptive use of plerixafor in patients with lymphoma and multiple myeloma which was administered as a preemptive single dose to the patients who were determined to have a CD34+ cell count of
Zitieren
APA
UYSAL, A., ERKURT, M. A., KURU, I., KAYA, E., BERBER, I., SARICI, A., BICIM, S., KAYA, A., & HIDAYET, E. (2023). The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma. Marmara Medical Journal, 36(1), 65-71. https://doi.org/10.5472/marumj.1244684
Vancouver
UYSAL A, ERKURT MA, KURU I, KAYA E, BERBER I, SARICI A, et al. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma. Marmara Medical Journal. 2023;36(1):65-71. doi:10.5472/marumj.1244684
BibTeX
@article{UYSAL2023,
author = {UYSAL, Ayse and ERKURT, Mehmet Ali and KURU, Irfan and KAYA, Emin and BERBER, Ilhami and SARICI, Ahmet and BICIM, Soykan and KAYA, Ahmet and HIDAYET, Emine},
title = {The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma},
journal = {Marmara Medical Journal},
year = {2023},
volume = {36},
number = {1},
pages = {65--71},
doi = {10.5472/marumj.1244684}
}
EUVIMED